Kathryn A. Phillips

Kathryn A. Phillips

University of California, San Francisco

H-index: 58

North America-United States

About Kathryn A. Phillips

Kathryn A. Phillips, With an exceptional h-index of 58 and a recent h-index of 27 (since 2020), a distinguished researcher at University of California, San Francisco,

His recent articles reflect a diverse array of research interests and contributions to the field:

Paving the path for implementation of clinical genomic sequencing globally-Are we ready?

HPR157 Payer Perspectives on Health Insurance Coverage for Digital Therapeutics in the United States

Six months, strong impact

Private payer and Medicare coverage policies for use of circulating tumor DNA tests in cancer diagnostics and treatment

Introducing the inaugural issue of Health Affairs Scholar: Emerging and Global Health Policy (HAS)

Health Affairs Scholar Launches Its Inaugural Issue

Ten health policy challenges for the next 10 years

The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non–Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis

Kathryn A. Phillips Information

University

Position

Professor

Citations(all)

13472

Citations(since 2020)

3274

Cited By

11254

hIndex(all)

58

hIndex(since 2020)

27

i10Index(all)

152

i10Index(since 2020)

72

Email

University Profile Page

University of California, San Francisco

Google Scholar

View Google Scholar Profile

Top articles of Kathryn A. Phillips

Title

Journal

Author(s)

Publication Date

Paving the path for implementation of clinical genomic sequencing globally-Are we ready?

Health Affairs Scholar

Deborah A Marshall

Nicolle Hua

James Buchanan

Kurt D Christensen

Geert WJ Frederix

...

2024/4/29

HPR157 Payer Perspectives on Health Insurance Coverage for Digital Therapeutics in the United States

Value in Health

X Liang

A Gómez-Lumbreras

S Schippers

S Bhattacharjee

H Waters

...

2023/6/1

Six months, strong impact

Health Affairs

Kathryn A Phillips

2023/7

Private payer and Medicare coverage policies for use of circulating tumor DNA tests in cancer diagnostics and treatment

Journal of the National Comprehensive Cancer Network

Michael P Douglas

Meera V Ragavan

Cheng Chen

Anika Kumar

Stacy W Gray

...

2023/6/1

Introducing the inaugural issue of Health Affairs Scholar: Emerging and Global Health Policy (HAS)

Kathryn A Phillips

2023/7

Health Affairs Scholar Launches Its Inaugural Issue

Health Affairs Forefront

Kathryn A Phillips

2023

Ten health policy challenges for the next 10 years

Health Affairs Scholar

Kathryn A Phillips

Deborah A Marshall

Loren Adler

Jose Figueroa

Simon F Haeder

...

2023/7

The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non–Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis

Value in Health

Jeroen P Jansen

Meera V Ragavan

Cheng Chen

Michael P Douglas

Kathryn A Phillips

2023/12/1

Health Affairs Scholar Is Now Accepting Submissions

Health Affairs Forefront

Kathryn A Phillips

2023

Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy

Health Affairs Scholar

Julia R Trosman

Christine B Weldon

Allison W Kurian

Mary M Pasquinelli

Sheetal M Kircher

...

2023/7

Developing the 4R model for care delivery, coordination, and patient and their care partners self‐management for suspected or diagnosed Alzheimer’s disease and related dementias

Alzheimer's & Dementia

Christine B Weldon

Jessica Zwerling

Joanna Martin

Michael S Wolf

Bruce Rapkin

...

2023/12

HTA82 Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-Analysis

C Chen

MP Douglas

MV Ragavan

K Phillips

J Jansen

2023/6/1

Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests

Healthcare (Amsterdam, Netherlands)

Grace A Lin

Kathryn A Phillips

A Mark Fendrick

2023/9

Influence of payer coverage and out‐of‐pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings

Journal of genetic counseling

Grace A Lin

Julia R Trosman

Michael P Douglas

Christine B Weldon

Maren T Scheuner

...

2022/2

Report–Cost and Clinical Utility of WES and WGS in pediatric patients with suspected genetic disease

medRxiv

Michael P Douglas

Patricia A Deverka

Bruce Gelb

Bart Ferket

Kristen Hassmiller Lich

...

2022/10/13

Medicare “Coverage With Evidence Development” Leaps Into The Spotlight With CMS Draft National Coverage Decision On Alzheimer’s Drugs

Health Affairs Forefront

Kathryn A Phillips

Rita F Redberg

2022

CMS coverage with evidence development—challenges and opportunities for improvement

Kathryn A Phillips

2022/9/2

Geriatricians’ perspectives on the multiple dimensions of utility of genetic testing for Alzheimer’s disease: A qualitative study

Journal of Alzheimer's Disease

Jalayne J Arias

Grace A Lin

Ana M Tyler

Michael P Douglas

Kathryn A Phillips

2022/1/1

Assessments of the value of new interventions should include health equity impact

PharmacoEconomics

Jeroen P Jansen

Thomas A Trikalinos

Kathryn A Phillips

2022/5

US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium …

Genetics in Medicine

Kathryn A Phillips

Julia R Trosman

Michael P Douglas

Bruce D Gelb

Bart S Ferket

...

2022/1/1

See List of Professors in Kathryn A. Phillips University(University of California, San Francisco)